GW501516    AO1_L_S_OW0 N_OW1_N AE1_Z GW 501 516    GW1516    GSK 516    Cardarine    AH0_N_D AA1_N DH_AH0 B_L_AE1_K M_AA1_R_K_AH0_T AE1_Z Endurobol     IH1_Z AH0 PPAR δ  R_IY0_S_EH1_P_T_ER0 AE1_G_AH0_N_IH0_S_T DH_AE1_T W_AA1_Z IH2_N_V_EH1_N_T_AH0_D IH0_N AH0 K_AH0_L_AE2_B_ER0_EY1_SH_AH0_N B_IH0_T_W_IY1_N Ligand Pharmaceuticals AH0_N_D GlaxoSmithKline IH0_N DH_AH0 1990s    W_AA1_Z EH1_N_T_ER0_D IH1_N_T_UW0 K_L_IH1_N_AH0_K_AH0_L D_IH0_V_EH1_L_AH0_P_M_AH0_N_T AE1_Z AH0 D_R_AH1_G K_AE1_N_D_AH0_D_EY0_T F_AO1_R M_EH2_T_AH0_B_AA1_L_IH0_K D_IH0_Z_IY1_Z_AH0_Z AH0_N_D K_AA2_R_D_IY0_OW0_V_AE1_S_K_Y_AH0_L_ER0 D_IH0_Z_IY1_Z_AH0_Z    AH0_N_D W_AA1_Z AH0_B_AE1_N_D_AH0_N_D IH0_N 2007 B_IH0_K_AO1_Z AE1_N_AH0_M_AH0_L T_EH1_S_T_IH0_NG SH_OW1_D DH_AE1_T DH_AH0 D_R_AH1_G K_AA1_Z_D K_AE1_N_S_ER0 T_UW1 D_IH0_V_EH1_L_AH0_P R_AE1_P_AH0_D_L_IY0 IH0_N S_EH1_V_ER0_AH0_L AO1_R_G_AH0_N_Z    In 2007 R_IY0_S_ER1_CH W_AA1_Z P_AH1_B_L_IH0_SH_T SH_OW1_IH0_NG DH_AE1_T HH_AY1 D_OW1_S_AH0_Z AH1_V GW501516 G_IH1_V_AH0_N T_UW1 M_AY1_S D_R_AH0_M_AE1_T_IH0_K_L_IY0 IH2_M_P_R_UW1_V_D DH_EH1_R F_IH1_Z_IH0_K_AH0_L P_ER0_F_AO1_R_M_AH0_N_S ;  DH_AH0 W_ER1_K W_AA1_Z W_AY1_D_L_IY0 D_IH0_S_K_AH1_S_T IH0_N P_AA1_P_Y_AH0_L_ER0 M_IY1_D_IY0_AH0    AH0_N_D L_EH1_D T_UW1 AH0 B_L_AE1_K M_AA1_R_K_AH0_T F_AO1_R DH_AH0 D_R_AH1_G K_AE1_N_D_AH0_D_EY0_T AH0_N_D T_UW1 IH1_T_S AH0_B_Y_UW1_S B_AY1 AE1_TH_L_IY2_T_S AE1_Z AH0 doping EY1_JH_AH0_N_T The World Anti Doping Agency    WADA    D_IH0_V_EH1_L_AH0_P_T AH0 T_EH1_S_T F_AO1_R GW501516 AH0_N_D AH1_DH_ER0 R_IH0_L_EY1_T_IH0_D K_EH1_M_IH0_K_AH0_L_Z AH0_N_D AE1_D_IH0_D DH_EH1_M T_UW1 DH_AH0 P_R_OW0_HH_IH1_B_AH0_T_AH0_D L_IH1_S_T IH0_N 2009 ;  IH1_T HH_AE1_Z IH1_SH_UW0_D AH0_D_IH1_SH_AH0_N_AH0_L W_AO1_R_N_IH0_NG_Z T_UW1 AE1_TH_L_IY2_T_S DH_AE1_T GW501516 IH1_Z N_AA1_T S_EY1_F GW501516 W_AA1_Z IH2_N_IH1_SH_AH0_L_IY0 D_IH0_S_K_AH1_V_ER0_D D_UH1_R_IH0_NG AH0 R_IY0_S_ER1_CH K_AH0_L_AE2_B_ER0_EY1_SH_AH0_N B_IH0_T_W_IY1_N GSK AH0_N_D Ligand Pharmaceuticals DH_AE1_T B_IH0_G_AE1_N IH0_N 1992    The D_IH0_S_K_AH1_V_ER0_IY0 AH1_V DH_AH0 K_AA1_M_P_AW0_N_D W_AA1_Z P_AH1_B_L_IH0_SH_T IH0_N AH0 2001 IH1_SH_UW0 AH1_V PNAS    Oliver EH1_T AE1_L R_IY2_P_AO1_R_T_AH0_D DH_AE1_T DH_EY1 Y_UW1_Z_D    combinatorial K_EH1_M_IH0_S_T_R_IY0 AH0_N_D S_T_R_AH1_K_CH_ER0 B_EY1_S_T D_R_AH1_G D_IH0_Z_AY1_N    T_UW1 D_IH0_V_EH1_L_AH0_P IH1_T    One AH1_V DH_AH0 AO1_TH_ER0_Z W_AA1_Z DH_AH0 S_AH1_N AH1_V Leo Sternbach HH_UW1 D_IH0_S_K_AH1_V_ER0_D benzodiazepines IH0_N DH_AH0 1960s     &  Focus Drug News R_IY2_P_AO1_R_T_AH0_D DH_AE1_T GSK B_IH0_G_AE1_N F_EY1_Z T_R_AY1_AH0_L_Z AH1_V DH_AH0 K_AA1_M_P_AW0_N_D F_AO1_R DH_AH0 T_R_IY1_T_M_AH0_N_T AH1_V hyperlipidemia IH0_N 2000    F_AA1_L_OW0_D B_AY1 F_EY1_Z II IH0_N 2002    In 2003    Ligand Pharmaceuticals ER1_N_D AH0  $ M_IH1_L_Y_AH0_N P_EY1_M_AH0_N_T AE1_Z AH0 R_IH0_Z_AH1_L_T AH1_V GSK K_AH0_N_T_IH1_N_Y_UW0_IH0_NG F_EY1_Z D_IH0_V_EH1_L_AH0_P_M_AH0_N_T    By 2007    GW501516 HH_AE1_D K_AH0_M_P_L_IY1_T_AH0_D T_UW1 F_EY1_Z II K_L_IH1_N_AH0_K_AH0_L S_T_AH1_D_IY0_Z AH0_N_D AH1_DH_ER0 S_T_AH1_D_IY0_Z R_IH0_L_EY1_T_IH0_NG T_UW1 OW0_B_IY1_S_AH0_T_IY0    D_AY2_AH0_B_IY1_T_IY0_Z    dyslipidemia AH0_N_D K_AA2_R_D_IY0_OW0_V_AE1_S_K_Y_AH0_L_ER0 D_IH0_Z_IY1_Z      B_AH1_T GSK AH0_B_AE1_N_D_AH0_N_D F_ER1_DH_ER0 D_IH0_V_EH1_L_AH0_P_M_AH0_N_T AH1_V DH_AH0 D_R_AH1_G IH0_N 2007 F_AO1_R R_IY1_Z_AH0_N_Z W_IH1_CH W_ER1 N_AA1_T D_IH0_S_K_L_OW1_Z_D AE1_T DH_AH0 T_AY1_M    It L_EY1_T_ER0 IH0_M_ER1_JH_D DH_AE1_T DH_AH0 D_R_AH1_G W_AA1_Z D_IH0_S_K_AH0_N_T_IH1_N_Y_UW0_D B_IH0_K_AO1_Z AE1_N_AH0_M_AH0_L T_EH1_S_T_IH0_NG SH_OW1_D DH_AE1_T DH_AH0 D_R_AH1_G K_AA1_Z_D K_AE1_N_S_ER0 T_UW1 D_IH0_V_EH1_L_AH0_P R_AE1_P_AH0_D_L_IY0 IH0_N S_EH1_V_ER0_AH0_L AO1_R_G_AH0_N_Z    AE1_T D_OW1_S_IH0_JH_IH0_Z AH1_V mg kg D_EY1 IH0_N B_OW1_TH M_AY1_S AH0_N_D R_AE1_T_S      Ronald Evans EH1_S L_AE1_B_R_AH0_T_AO2_R_IY0 P_ER1_CH_AH0_S_T AH0 S_AE1_M_P_AH0_L AH1_V GW501516 AH0_N_D G_EY1_V M_AY1_S AH0 M_AH1_CH HH_AY1_ER0 D_OW1_S DH_AE1_N HH_AE1_D B_IH1_N Y_UW1_Z_D IH0_N GSK EH1_S IH0_K_S_P_EH1_R_AH0_M_AH0_N_T_S ;  DH_EY1 F_AW1_N_D DH_AE1_T DH_AH0 K_AA1_M_P_AW0_N_D D_R_AH0_M_AE1_T_IH0_K_L_IY0 IH2_N_K_R_IY1_S_T DH_AH0 F_IH1_Z_IH0_K_AH0_L P_ER0_F_AO1_R_M_AH0_N_S AH1_V DH_AH0 M_AY1_S The W_ER1_K W_AA1_Z P_AH1_B_L_IH0_SH_T IH0_N 2007 IH0_N Cell AH0_N_D W_AA1_Z W_AY1_D_L_IY0 R_IY2_P_AO1_R_T_AH0_D IH0_N DH_AH0 P_AA1_P_Y_AH0_L_ER0 P_R_EH1_S IH2_N_K_L_UW1_D_IH0_NG The New York Times AH0_N_D The Wall Street Journal    Concerns W_ER1 R_EY1_Z_D P_R_AY1_ER0 T_UW1 DH_AH0 2008 Beijing Olympics DH_AE1_T GW501516 K_UH1_D B_IY1 Y_UW1_Z_D B_AY1 AE1_TH_L_IY2_T_S AE1_Z AE1_N ergogenic P_ER0_F_AO1_R_M_AH0_N_S EH0_N_HH_AE1_N_S_IH0_NG D_R_AH1_G DH_AE1_T W_AA1_Z N_AA1_T K_ER1_AH0_N_T_L_IY0 K_AH0_N_T_R_OW1_L_D B_AY1 R_EH2_G_Y_AH0_L_EY1_SH_AH0_N_Z AO1_R D_IH0_T_EH1_K_T_AH0_D B_AY1 S_T_AE1_N_D_ER0_D T_EH1_S_T_S One AH1_V DH_AH0 M_EY1_N R_IY1_S_ER0_CH_ER0_Z F_R_AH1_M DH_AH0 S_T_AH1_D_IY0 AA1_N EH0_N_HH_AE1_N_S_T EH1_N_D_ER0_AH0_N_S K_AA1_N_S_AH0_K_W_AH0_N_T_L_IY0 D_IH0_V_EH1_L_AH0_P_T AH0 Y_ER1_AH0_N T_EH1_S_T T_UW1 D_IH0_T_EH1_K_T DH_AH0 D_R_AH1_G    AH0_N_D M_EY1_D IH1_T AH0_V_EY1_L_AH0_B_AH0_L T_UW1 DH_AH0 International Olympic Committee The World Anti Doping Agency    WADA    D_IH0_V_EH1_L_AH0_P_T AH0 T_EH1_S_T F_AO1_R GW501516 AH0_N_D AH1_DH_ER0 R_IH0_L_EY1_T_IH0_D PPAR δ  modulators     AH0_N_D AE1_D_IH0_D S_AH1_CH D_R_AH1_G_Z T_UW1 DH_AH0 P_R_OW0_HH_IH1_B_AH0_T_AH0_D L_IH1_S_T IH0_N 2009    GW501516 HH_AE1_Z B_IH1_N P_R_AH0_M_OW1_T_AH0_D AA1_N bodybuilding AH0_N_D AE0_TH_L_EH1_T_IH0_K_S W_EH1_B_S_AY2_T_S     AH0_N_D B_AY1 2011 HH_AE1_D AO0_L_R_EH1_D_IY0 B_IH1_N AH0_V_EY1_L_AH0_B_AH0_L F_AO1_R S_AH1_M T_AY1_M AA1_N DH_AH0 B_L_AE1_K M_AA1_R_K_AH0_T     In 2011 IH1_T W_AA1_Z R_IY2_P_AO1_R_T_AH0_D T_UW1 K_AA1_S_T  $ 1000 F_AO1_R 10 JH_IY1     In 2012    WADA recategorised GW501516 F_R_AH1_M AH0 JH_IY1_N doping K_AA1_M_P_AW0_N_D T_UW1 AH0    HH_AO1_R_M_OW2_N AH0_N_D M_EH2_T_AH0_B_AA1_L_IH0_K M_AA1_JH_AH0_L_EY2_T_ER0    In 2013    WADA T_UH1_K DH_AH0 R_EH1_R S_T_EH1_P AH1_V W_AO1_R_N_IH0_NG P_AH0_T_EH1_N_SH_AH0_L Y_UW1_Z_ER0_Z AH1_V DH_AH0 K_AA1_M_P_AW0_N_D AH1_V DH_AH0 P_AA1_S_AH0_B_AH0_L HH_EH1_L_TH R_IH1_S_K_S    S_T_EY1_T_IH0_NG DH_AE1_T    K_L_IH1_N_AH0_K_AH0_L AH0_P_R_UW1_V_AH0_L HH_AE1_Z N_AA1_T    AH0_N_D W_IH1_L N_AA1_T B_IY1 G_IH1_V_AH0_N F_AO1_R DH_IH1_S S_AH1_B_S_T_AH0_N_S  ;  DH_AH0 New Scientist AH0_T_R_IH1_B_Y_AH0_T_AH0_D DH_AH0 W_AO1_R_N_IH0_NG T_UW1 DH_AH0 R_IH1_S_K_S AH1_V DH_AH0 D_R_AH1_G K_AA1_Z_IH0_NG K_AE1_N_S_ER0     N_AH1_M_B_ER0 AH1_V AE1_TH_L_IY2_T_S HH_AE1_V T_EH1_S_T_IH0_D P_AA1_Z_AH0_T_IH0_V F_AO1_R GW501516    At DH_AH0 Vuelta Ciclista AH0 Costa Rica IH0_N December 2012    F_AO1_R Costa Rican R_AY1_D_ER0_Z T_EH1_S_T_IH0_D P_AA1_Z_AH0_T_IH0_V F_AO1_R GW501516 Three AH1_V DH_EH1_M R_AH0_S_IY1_V_D T_UW1 Y_IH1_R S_AH0_S_P_EH1_N_SH_AH0_N_Z    W_AY1_L DH_AH0 F_AO1_R_TH R_AH0_S_IY1_V_D 12 Y_IH1_R_Z AE1_Z IH1_T W_AA1_Z HH_IH1_Z S_EH1_K_AH0_N_D doping V_AY0_AH0_L_EY1_SH_AH0_N       In April 2013    Russian S_AY1_K_AH0_L_IH0_S_T Valery Kaykov W_AA1_Z S_AH0_S_P_EH1_N_D_AH0_D B_AY1 S_AY1_K_AH0_L_IH0_NG EH1_S G_AH1_V_ER0_N_IH0_NG B_AA1_D_IY0 UCI AE1_F_T_ER0 HH_AE1_V_IH0_NG T_EH1_S_T_IH0_D P_AA1_Z_AH0_T_IH0_V F_AO1_R GW501516 Kaykov EH1_S T_IY1_M RusVelo D_IH0_S_M_IH1_S_T HH_IH1_M IH2_M_IY1_D_IY2_AH0_T_L_IY0    AH0_N_D IH0_N May 2013    Venezuelan Miguel Ubeto W_AA1_Z P_R_AH0_V_IH1_ZH_AH0_N_AH0_L_IY0 S_AH0_S_P_EH1_N_D_AH0_D B_AY1 DH_AH0 Lampre T_IY1_M     In February 2014    Russian R_EY1_S W_AO1_K_ER0 Elena Lashmanova T_EH1_S_T_IH0_D P_AA1_Z_AH0_T_IH0_V F_AO1_R GW501516     GW501516 IH1_Z AH0 S_AH0_L_EH1_K_T_IH0_V AE1_G_AH0_N_IH0_S_T    AE1_K_T_AH0_V_EY2_T_ER0    AH1_V DH_AH0 PPAR δ  R_IY0_S_EH1_P_T_ER0    It D_IH0_S_P_L_EY1_Z HH_AY1 AH0_F_IH1_N_IH0_T_IY0    Ki  =  nM    AH0_N_D P_OW1_T_AH0_N_S_IY0    EC50  =  nM    F_AO1_R PPAR δ  W_IH1_DH  >  1000 F_OW1_L_D S_IH0_L_EH2_K_T_IH1_V_AH0_T_IY0 OW1_V_ER0 PPAR α  AH0_N_D PPAR    In R_AE1_T_S    B_AY1_N_D_IH0_NG AH1_V GW501516 T_UW1 PPAR δ  R_AH0_K_R_UW1_T_S DH_AH0 coactivator PGC    The PPAR δ/ coactivator K_AA1_M_P_L_EH0_K_S IH0_N T_ER1_N upregulates DH_AH0 IH0_K_S_P_R_EH1_SH_AH0_N AH1_V P_R_OW1_T_IY2_N_Z IH2_N_V_AA1_L_V_D IH0_N EH1_N_ER0_JH_IY0 IH0_K_S_P_EH1_N_D_AH0_CH_ER0     Furthermore    IH0_N R_AE1_T_S T_R_IY1_T_AH0_D W_IH1_DH GW501516    IH2_N_K_R_IY1_S_T F_AE1_T_IY0 AE1_S_AH0_D M_AH0_T_AE1_B_AH0_L_IH2_Z_AH0_M IH0_N S_K_EH1_L_AH0_T_AH0_L M_AH1_S_AH0_L AH0_N_D P_R_AH0_T_EH1_K_SH_AH0_N AH0_G_EH1_N_S_T D_AY1_AH0_T IH2_N_D_UW1_S_T OW0_B_IY1_S_AH0_T_IY0 AH0_N_D T_AY1_P II D_AY2_AH0_B_IY1_T_IY0_Z W_AA1_Z AH0_B_Z_ER1_V_D    In OW0_B_IY1_S R_IY1_S_AH0_S M_AH1_NG_K_IY0_Z    GW501516 IH2_N_K_R_IY1_S_T HH_AY1 D_EH1_N_S_AH0_T_IY0 L_IH2_P_AH0_P_R_OW1_T_IY0_N    HDL    AH0_N_D L_OW1_ER0_D V_EH1_R_IY0 L_OW1 D_EH1_N_S_AH0_T_IY0 L_IH2_P_AH0_P_R_OW1_T_IY0_N    VLDL   